EXTRACELLULAR MATRIX IN SYNAPSE FORMATION IN THE CNS
中枢神经系统突触形成中的细胞外基质
基本信息
- 批准号:6446640
- 负责人:
- 金额:$ 14.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:animal tissue central nervous system confocal scanning microscopy electrophysiology extracellular matrix gene targeting genetically modified animals immunocytochemistry in situ hybridization laboratory mouse laminin organ culture protein structure function receptor binding retina retina degeneration retinal bipolar neuron rod cell synaptogenesis visual photoreceptor
项目摘要
DESCRIPTION (Verbatim from applicant's abstract): Laminins are
biologically-active molecules which function as cell adhesion molecules,
regulate various aspects of development, and serve to stabilize complex
anatomical structures. They are large extracellular matrix molecules that are
composed of three subunit chains, designated alpha, beta and gamma. Five alpha,
three beta and three gamma chains have been identified. Several disorders of
the nervous system are linked to laminin genes: some congenital muscular
dystrophies involve the alpha2 chain (merosin); the beta2 chain is reduced in
Walker-Warburg syndrome, and a complex group of CNS developmental disorders
(muscle-brain-eye disease; retinitis pigmentosa with deafness (RP21 with
deafness); Walker-Warburg syndrome) map to the site of the gamma3 gene.
Laminins are widely expressed in the CNS; we have shown that in the human, rat,
bovine and mouse retina, four laminin chains (alpha3, alpha4, beta2 and gamma3)
are found in the interphotoreceptor matrix and in the matrix of the outer
plexiform layer (OPL). These chains are likely to form two heterotrimers,
laminin-13 and laminin-14. The retinal laminin chains appear to play important
roles in the morphogenesis of photoreceptors; first, these chains are expressed
prior to the onset of rod genesis and persist into adulthood; second, ablation
of the gene encoding one of the chains, beta2, results in the production of
dysmorphic photoreceptors with aberrant function. Specifically, photoreceptor
outer segments are reduced in length; the photoreceptor terminal in the OPL are
disrupted: finally, in ERGs, the amplitude of the b-wave is drastically
diminished, suggesting that transmission between photoreceptors and bipolar
cells is disrupted by loss of laminin beta2 chain function. We hypothesize that
laminins-13 and -14 are critical mediators of synapse formation and
stabilization between photoreceptors and second order cells in the OPL.
Furthermore, we hypothesize that laminins-13 and -14 form unique substrates
with which photoreceptor axons interact and to which they adhere in order to
elaborate synapses, and, finally, that the molecular structure of the synapse
is dependent on the interactions between these laminins and their receptors. We
propose to test several aspects of this hypothesis. We will ask several
specific questions: (1) what the spatial and temporal expression of
laminin-binding molecules is in the OPL; (2) whether these molecules mediate
the binding of cells to OPL laminins; and (3) what anatomical and physiological
alterations in the photoreceptor synapse result from laminin gene disruptions.
描述(来自申请人摘要的逐字描述):层粘连蛋白是
起细胞粘附分子作用的生物活性分子,
规范发展的各个方面,并服务于稳定复杂的
解剖结构它们是大的细胞外基质分子,
由三条亚基链组成,分别命名为α、β和γ。阿尔法5号,
已经鉴定了三个β和三个γ链。几种疾病
神经系统与层粘连蛋白基因有关:一些先天性肌肉
营养不良涉及α 2链(裂球蛋白); β 2链减少,
沃克-沃伯格综合征和一组复杂的中枢神经系统发育障碍
(肌-脑-眼疾病;视网膜色素变性伴耳聋(RP 21伴
耳聋);沃克-沃伯格综合征)映射到γ 3基因的位点。
层粘连蛋白在中枢神经系统中广泛表达;我们已经表明,在人类,大鼠,
牛和小鼠视网膜,四条层粘连蛋白链(α 3、α 4、β 2和γ 3)
存在于感光细胞间基质和外膜基质中
网状层(OPL)。这些链可能形成两个异源三聚体,
层粘连蛋白-13和层粘连蛋白-14。视网膜层粘连蛋白链似乎在
在光感受器的形态发生中的作用;首先,这些链被表达
在视杆细胞发生之前,并持续到成年期;第二,消融
编码β 2链的基因的突变,
具有异常功能的畸形光感受器。特别是感光细胞
外节的长度减少; OPL中的感光末梢
中断:最后,在ERG中,b波的振幅急剧下降,
减少,表明光感受器和双极之间的传输
细胞因层粘连蛋白β 2链功能丧失而受到破坏。我们假设
层粘连蛋白-13和-14是突触形成的关键介质,
光感受器和OPL中的二级细胞之间的稳定。
此外,我们假设层粘连蛋白-13和-14形成独特的底物,
光感受器轴突与其相互作用并粘附于其上,
最后,突触的分子结构
依赖于这些层粘连蛋白和它们的受体之间的相互作用。我们
我想测试这个假设的几个方面。我们会问几个
具体问题:(1)空间和时间的表达
层粘连蛋白结合分子在OPL中;(2)这些分子是否介导
细胞与OPL层粘连蛋白的结合;以及(3)解剖学和生理学上
光感受器突触的改变是由层粘连蛋白基因破坏引起的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM J BRUNKEN其他文献
WILLIAM J BRUNKEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM J BRUNKEN', 18)}}的其他基金
Role of Extracellular Matrix in Retinal Development and Disease
细胞外基质在视网膜发育和疾病中的作用
- 批准号:
10330943 - 财政年份:2019
- 资助金额:
$ 14.71万 - 项目类别:
Role of Extracellular Matrix in Retinal Development and Disease
细胞外基质在视网膜发育和疾病中的作用
- 批准号:
8512409 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
Extracellular matrix in synapse formation in the CNS
中枢神经系统突触形成中的细胞外基质
- 批准号:
6929077 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
Role of Extracellular Matrix in Retinal Development and Disease
细胞外基质在视网膜发育和疾病中的作用
- 批准号:
7992716 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
EXTRACELLULAR MATRIX IN SYNAPSE FORMATION IN THE CNS
中枢神经系统突触形成中的细胞外基质
- 批准号:
6384826 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
STRUCTURE AND FUNCTION OF NON BASEMENT MEMBRANE LAMININS
非基底膜层粘连蛋白的结构和功能
- 批准号:
6499449 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
Extracellular matrix in synapse formation in the CNS
中枢神经系统突触形成中的细胞外基质
- 批准号:
7087782 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
Extracellular matrix in synapse formation in the CNS
中枢神经系统突触形成中的细胞外基质
- 批准号:
7251457 - 财政年份:2000
- 资助金额:
$ 14.71万 - 项目类别:
相似海外基金
Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
- 批准号:
EP/X027198/2 - 财政年份:2024
- 资助金额:
$ 14.71万 - 项目类别:
Fellowship
Strategy to Attack Coronavirus Infections Brain Fog-Central Nervous System Sequelae Using a Novel Patented Technology
利用新型专利技术对抗冠状病毒感染脑雾-中枢神经系统后遗症的策略
- 批准号:
23K10453 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune cells protecting from lethal viral infection in the central nervous system
鉴定中枢神经系统免受致命病毒感染的免疫细胞
- 批准号:
22KJ1176 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of metabolic control mechanism by FGF21-mediated central nervous system signaling in neonatal period
阐明新生儿期 FGF21 介导的中枢神经系统信号传导的代谢控制机制
- 批准号:
23K10836 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Central nervous system inflammation due to a high-fat diet and changes in exercise volume - effects on obesity
高脂肪饮食和运动量变化引起的中枢神经系统炎症——对肥胖的影响
- 批准号:
23K10646 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
2023 Central Nervous System Injury and Repair Gordon Research Conference and Seminar
2023中枢神经系统损伤与修复戈登研究会议暨研讨会
- 批准号:
10753737 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Maladaptive Remodeling of the Neuromuscular Synapse Following Central Nervous System Injury
中枢神经系统损伤后神经肌肉突触的适应不良重塑
- 批准号:
10569935 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Effects of Central Nervous System Agents on Next Generation Development via Changes in Sperm DNA Methylation
中枢神经系统药物通过精子 DNA 甲基化的变化对下一代发育的影响
- 批准号:
23K19438 - 财政年份:2023
- 资助金额:
$ 14.71万 - 项目类别:
Grant-in-Aid for Research Activity Start-up